MetaCap

Regencell Bioscience Insider Trades

NASDAQ: RGCHealth Care Medicinal Chemicals and Botanical Products USD

4.18-0.18 (-4.13%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Regencell Bioscience insider activity

Over the last 12 months, Regencell Bioscience insiders reported 1 transaction on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows LO WILLIAM WING YAN DR (Director) reporting a transaction in 36,001 shares at $0.84 on Nov 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put RGC's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

RGC insider transactions

Regencell Bioscience insider transactions
DateInsiderTypeSharesValueFiling
Nov 17, 2026LO WILLIAM WING YAN DRDirectorOption exercise36,001$30.24KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related